Bookmark

Add to MyYahoo RSS

GlaxoSmithKline News

News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.

18 hrs ago | Seeking Alpha

3 Household-Name Stocks With Dividend Yields Over 3% And P/E Ratios Under 15

It has become increasingly difficult to find strong businesses trading at low P/E ratios in today's overvalued market.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, ConocoPhillips, Energy, Oil & Gas

Yesterday | Business News

China syndrome bodes ill for GlaxoSmithKline's results

We've had the sex and the drugs, but sadly no rock'n'roll in the saga of GlaxoSmithKline 's murky dealings in China.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Apple, Startups

Sun Jul 20, 2014

Sunday Herald

Glaxo link to probe

Drugs giant GlaxoSmithKline publishes second quarter results on Wednesday as a tangled web of allegations linked to a bribery probe by Chinese authorities continues to hang over the UK-based company.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

Live Charts

Sunday newspaper round-up: BSkyB, FX inquiry, GlaxoSmithKline

BSkyB is putting the final touches to a plan to buy its sister companies in Italy and Germany and will announce the takeovers in the next two weeks, the Sunday Times reported.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Shooting People

NewsTarget.com

Irrefutable proof that Big Pharma is a criminal racket: Bribery,...

Those of us who have long been describing the pharmaceutical industry as a "criminal racket" over the last few years have been wholly vindicated by recent news.

Comment?

Related Topix: Prison, Pharmaceuticals, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Healthcare Law, Law

Sat Jul 19, 2014

AmericanBankingNews.com

GlaxoSmithKline plc Receives Consensus Rating of "Hold" from Analysts

Shares of GlaxoSmithKline plc have been given a consensus rating of "Hold" by the seventeen analysts that are covering the stock, StockRatingsNetwork.com reports .

Comment?

Related Topix: Biotech, GlaxoSmithKline, Medicine, Healthcare Industry

Fri Jul 18, 2014

BioSpace

Novartis AG Plant To Fall Under GlaxoSmithKline Control

The cost consequences of the Lincoln Novartis plant's two and a half years of quality-control troubles appear to be fading away as it restores more production and approaches new ownership and a new name, GSK Consumer Healthcare.

Comment?

Related Topix: Biotech

Live Charts

Broker tips: GlaxoSmithKline, AstraZeneca, Housebuilders

Panmure Gordon said it is "not expecting fireworks" from GlaxoSmithKline's second-quarter results due out next Wednesday.

Comment?

Related Topix: Biotech, AstraZeneca Group

Thu Jul 17, 2014

Wall Street Journal

China Allows Open Trial for Glaxo Investigators

Chinese authorities said they plan to hold an open trial when they try two foreign investigators tied to U.K. drug giant GlaxoSmithKline PLC on charges of illegally purchasing personal information on Chinese nationals.

Comment?

Related Topix: Biotech

Seeking Alpha

Wall Street Breakfast: Russian Sanctions, Glaxo Guilty, VW-Fiat Rumor

Economy The IMF praised the formation of the New Development Bank and reserves fund launched by BRICS countries yesterday, and announced that it would like to work together with the monumental project.

Comment?

Related Topix: Vladimir Putin, Biotech, Microsoft, Startups, Sentillion, Home, Mortgage, Personal Finance

Benzinga

Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine ...

Mylan Inc. today announced that the U.S. District Court for the District of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to Paroxetine CR, the generic version of GSK's PaxilA CR.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Dey, Startups, GlaxoSmithKline

Thanh Nein News

GSK confirms it fired staff for corruption in China in 2001

GlaxoSmithKline said it fired staff in China for bribing officials in 2001 in a case that predates wider allegations of corruption for the British drugmaker in the country by more than a decade.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Wed Jul 16, 2014

The Modesto Bee

Novartis cites momentum in 3 percent profit rise

Profits during the April-June quarter rose to $3.28 billion, up from $3.18 billion in the same quarter of 2013, helped by "strong innovation momentum" and rising sales in some of its household brands, the Basel-based company reported.

Comment?

Related Topix: Biotech, Novartis, Noven Pharmaceuticals, Medicine, Eli Lilly, Healthcare Industry, Business News

Law.com

Paxil Birth-Defect Mass Tort Set to Close in Philadelphia

The Paxil birth-defect litigation in Philadelphia, which once included about 1,000 cases, now has only two left in the city's court system.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, US News, Third Circuit Court of Appeals, Pennsylvania

NutraIngredients

'You, stronger?' Not via EU-approved protein-recovery claims, ASA tells MaxiNutrition

The UK advertising watchdog has dropped a barbell on drug giant GlaxoSmithKline's MaxiNutrition sports nutrition brand over "exaggerated" use of EU-approved protein-recovery claims.

Comment?

Related Topix: Biotech, Nutrition, Medicine

BioSpace

Isis Pharmaceuticals, Inc. Earns $1 Million From GSK For Advancing ISIS-TTR Rx

ISIS-TTRRx is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis, a severe and rare genetic disease characterized by progressive dysfunction of peripheral nerve and/or heart tissues.

Comment?

Related Topix: Biotech, Isis Pharmaceuticals, Medicine, Healthcare Industry, Genetics, Marketing

BioSpace

GlaxoSmithKline Begins Shipping 2014-15 U.S. Flu Vaccines

Expected 28 - 33 million doses of four-strain and three-strain flu shots will help meet U.S. public health needs GSK [LSE/NYSE: GSK] announced today it has begun shipping FLUARIXA QUADRIVALENT doses to U.S. healthcare providers.

Comment?

Related Topix: Medicine, Influenza, Health, Biotech, Food and Drug Administration, Centers for Disease Control and Prevention

AlertNet

Ex-GSK China staff seek compensation for illegal dismissal

Three former Chinese employees of GlaxoSmithKline PLC, which is embroiled in a long-running corruption probe in China, are seeking compensation for illegal dismissal from their jobs, a lawyer representing them told Reuters.

Comment?

Related Topix: Biotech

Sys-Con Media

GSK and Theravance Announce Initiation of Phase III Programme With...

IMPACT is the first pivotal phase III study in a programme to evaluate a once-daily closed triple combination treatment of an inhaled corticosteroid ; a long-acting muscarinic antagonist ; and a long-acting beta2-adrenergic agonist in patients with COPD.

Comment?

Related Topix: Biotech, Startups, Theravance, Medicine, GlaxoSmithKline, Healthcare Industry, Copd, Chronic Obstructive Pulmonary Disease

Tue Jul 15, 2014

TheStreet.com

Why Codexis (CDXS) Stock Hit a One-Year High Today

GSK can also use it to create new therapeutic, diagnostic and prophylactic products.

Comment?

Related Topix: Biotech

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••